BioMarin Pharmaceutical | BMRN

Aktienkurs
55.95
Täglich Wechseln
0.41 0.74%
Monatlich
4.48%
Jährlich
-0.48%
Q2 Prognose
54.81

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-05-04 FY2026Q1 PM 0.76 0.74 1.13
2026-02-23 FY2025Q4 PM 0.46 0.77 0.92
2025-10-27 FY2025Q3 PM 0.12 0.86 0.91
2025-08-04 FY2025Q2 PM 1.44 0.84 0.96
2025-05-01 FY2025Q1 PM 1.13 0.65 0.71



Preis Chg Tag Jahr Datum
Acadia Pharmaceuticals 21.09 -0.30 -1.40% -2.86% 2026-06-12
Agios Pharmaceuticals 29.46 0.74 2.58% -14.11% 2026-06-12
Alnylam Pharmaceuticals 282.85 -6.54 -2.26% -8.16% 2026-06-12
Amgen 355.20 1.14 0.32% 20.32% 2026-06-12
Bayer 36.19 0.40 1.12% 31.70% 2026-06-12
Biogen 200.05 0.09 0.05% 53.12% 2026-06-12
BioMarin Pharmaceutical 55.95 0.41 0.74% -0.48% 2026-06-12
Gilead Sciences 125.59 -0.28 -0.22% 14.19% 2026-06-12
Incyte 108.53 0.70 0.65% 60.19% 2026-06-12
Insmed 97.85 1.13 1.17% -0.89% 2026-06-12

Preis Tag Jahr Datum
USND 25889 79.18 0.31% 33.40% 2026-06-12